ProfileGDS4718 / 206170_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 40% 79% 48% 37% 39% 38% 42% 51% 34% 54% 51% 38% 29% 34% 56% 57% 29% 50% 41% 53% 47% 46% 45% 58% 26% 45% 25% 48% 57% 42% 33% 33% 51% 56% 36% 43% 50% 35% 83% 49% 47% 47% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6180232
GSM549102patient 115, normal, homogenized [OPG study]5.0318140
GSM549104patient 119, normal, homogenized [OPG study]7.7998479
GSM549108patient 138, normal, homogenized [OPG study]5.4581448
GSM549119patient 077, normal, homogenized [OPG study]4.8678337
GSM549133patient 032, cancer, homogenized [OPG study]4.9025439
GSM549139patient 042, cancer, homogenized [OPG study]4.8771638
GSM549099patient 107, normal, homogenized [OPG study]5.095142
GSM549109patient 139, normal, homogenized [OPG study]5.5642151
GSM549110patient 046, normal, homogenized [OPG study]4.731234
GSM549114patient 063, normal, homogenized [OPG study]5.7130554
GSM549122patient 082, normal, homogenized [OPG study]5.568651
GSM549134patient 033, cancer, homogenized [OPG study]4.9018738
GSM549136patient 036, cancer, homogenized [OPG study]4.4514829
GSM549140patient 044, cancer, homogenized [OPG study]4.6935234
GSM549111patient 047, normal, homogenized [OPG study]5.8655156
GSM549113patient 057, normal, homogenized [OPG study]5.8881357
GSM549132patient 031, cancer, homogenized [OPG study]4.5022129
GSM549137patient 038, cancer, homogenized [OPG study]5.4957950
GSM549142patient 047, cancer, homogenized [OPG study]5.1626141
GSM549100patient 110, normal, homogenized [OPG study]5.6673453
GSM549107patient 135, normal, homogenized [OPG study]5.2914747
GSM549115patient 068, normal, homogenized [OPG study]5.2569746
GSM549116patient 072, normal, homogenized [OPG study]5.2335245
GSM549120patient 078, normal, homogenized [OPG study]5.9941458
GSM549131patient 030, cancer, homogenized [OPG study]4.3240526
GSM549118patient 074, normal, homogenized [OPG study]5.2169745
GSM549129patient 027, cancer, homogenized [OPG study]4.3675925
GSM549123patient 088, normal, homogenized [OPG study]5.3684248
GSM549124patient 006, cancer, homogenized [OPG study]5.9353957
GSM549126patient 015, cancer, homogenized [OPG study]5.0587542
GSM549128patient 025, cancer, homogenized [OPG study]4.628333
GSM549103patient 117, normal, homogenized [OPG study]4.7472133
GSM549117patient 073, normal, homogenized [OPG study]5.5434851
GSM549138patient 041, cancer, homogenized [OPG study]5.8543756
GSM549141patient 045, cancer, homogenized [OPG study]4.7364436
GSM549130patient 028, cancer, homogenized [OPG study]5.1507643
GSM549101patient 111, normal, homogenized [OPG study]5.5441850
GSM549105patient 128, normal, homogenized [OPG study]4.7993935
GSM549106patient 134, normal, homogenized [OPG study]8.3660883
GSM549112patient 048, normal, homogenized [OPG study]5.4487849
GSM549125patient 011, cancer, homogenized [OPG study]5.3522947
GSM549127patient 024, cancer, homogenized [OPG study]5.3783747
GSM549135patient 035, cancer, homogenized [OPG study]4.401428